1. Papadopoulou A., Amil-Dias J., Auth M.K.-H. et al. Joint ESPGHAN/NASPGHAN Guidelines on Childhood Eosinophilic Gastrointestinal Disorders Beyond Eosinophilic Esophagitis. J Pediatr Gastroenterol Nutr. 2024; 78 (1): 122-152. DOI: 10.1097/MPG.0000000000003877
2. Redd W.D., Dellon E.S. Eosinophilic Gastrointestinal Diseases Beyond the Esophagus: An Evolving Field and Nomenclature. J Gastroenterol Hepatol. 2022; 18 (9): 522-528.
3. Клинические рекомендации “Эозинофильный эзофагит”. Министерство Здравоохранения Российской Федерации. 2022.URL: https://lyl.su/YJqZ (дата обращения 29.11.2024 г.).
4. Захарова И.Н., Османов И.М., Пампура А.Н. и соавторы. Эозинофильный эзофагит: все еще трудно и редко диагностируемое состояние. Клинический случай. Педиатрия. Consilium Medicum. 2021; 1: 57-62. DOI: 10.26442/26586630.2021.1.200838
5. Coutry E., Papadopoulou A. Eosinophilic diseases of the gastrointestinal tract in childhood. J Ann is Inside. 2018; 73 (4): 18-28. DOI: 10.1159/000493668
6. Dellon E.S., Hirano I. Epidemiology and natural history of eosinophilic esophagitis. Gastroenterology. 2018; 154 (2): 319-332. e3. DOI: 10.1053/j.gastro.2017.06.067
7. Han J.V., Lee K., Shin J.I. et al. Global incidence and prevalence of eosinophilic esophagitis, 1976-2022: a systematic review and meta-analysis. Klin Gastroenterol Hepatol. 2023; 21 (13): 3270-3284.e77. DOI: 10.1016/j.cgh.2023.06.005
8. Oliva S., McGowan E.C. Associations of Eosinophilic Gastrointestinal Disorders with Other Gastrointestinal and Allergic Diseases. Immunology and Allergy Clinics of North America. 2024; 44 (2): 329-348. DOI: 10.1016/j.iac.2024.01.005
9. Dillon E.S., Muir A.B., Katzka D.A. et al. Clinical Guidelines: Diagnosis and Treatment of eosinophilic esophagitis. American Journal of Gastroenterology. 2025; 120 (1): 31-59. DOI: 10.14309/ajg.000000000000003194
10. Amil-Dias J., Oliva S., Papadopoulou A. et al. Diagnosis and treatment of eosinophilic esophagitis in children: updated information from the European Society of Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN). J Pediatr Gastroenterol Nutr. 2024; 79 (2): 394-437. DOI: 10.1002/jpn3.12188
11. Kennedy K.V., Muir A.B., Ruffner M.A. Pathophysiology of Eosinophilic Esophagitis. Immunology and Allergy Clinics of North America. 2024; 44 (2): 119-128. DOI: 10.1016/j.iac.2023.12.001
12. Agulló-García A., Cubero J.L., Lezaun A. et al. Clinical and anatomopathological features of eosinophilic oesophagitis in children and adults. J Allergologia et Immunopathologia. 2020; 48 (6): 560-567. DOI: 10.1016/j.aller.2020.03.009
13. Aceves S.S., Alexander J.A., Baron T.H. et al. An endoscopic approach to eosinophilic esophagitis: Consensus Conference of the American Society for Gastrointestinal Endoscopy. Gastrointestinal endosc. 2022; 96 (4): 576-592.e1. DOI: 10.1016/j.gie.2022.05.013
14. Bolton S.M., Kagalwalla A.F., Arva N.K. et al. Mast cell infiltration is associated with persistent symptoms and endoscopic abnormalities, despite the resolution of eosinophilia in infantile eosinophilic esophagitis. Am J Gastroenterol. 2020; 115 (2): 224-233. DOI: 10.14309/ajg.00000000000000474
15. Morgan D.M., Ruiter B., Smith N. et al. Clonally expanded pathogenic effector T2 cells expressing GPR15 are associated with eosinophilic esophagitis. Sci Immunol. 2021; 6 (62): eabi5586. DOI: 10.1126/sciimmunol.abi5586
16. Kagalwalla A.F., Wexler J.B., Amsden K. et al. Effectiveness of the 4-food elimination diet for children with eosinophilic esophagitis. Wedge Gastroenterol Hepatol. 2017; 15 (11): 1698-1707.e7. DOI: 10.1016/j.cgh.2017.05.048
17. Lucendo A.J., Arias Á., Molina-Infante J. Efficacy of proton pump inhibitor drugs for inducing clinical and histologic remission in patients with symptomatic esophageal eosinophilia: a systematic review and meta-analysis. J Clin Gastroenterol Hepatol. 2016; 14 (1): 13-22.e1.
18. Dellon E.S., Woosley J.T., Arrington A. et al. The efficacy of budesonide versus fluticasone for the initial treatment of eosinophilic esophagitis in a randomized controlled trial. Gastroenterology. 2019; 157 (1): 65-73.e5. DOI: 10.1053/j.gastro.2019.03.014
19. Dellon E.S., Rotenberg M.E., Collins M.H. et al. Dupilumab in adults and adolescents with eosinophilic esophagitis. N Engl J Med. 2022; 387 (25): 2317-2330. DOI: 10.1056/NEJMoa2205982 EDN: KBBHKL
20. Chehade M., Dellon E.S., Spergel J.M. et al. Dupilumab for Eosinophilic Esophagitis in Patients 1 to 11 Y ears of Age. N Engl J Med. 2024; 390 (24): 2239-2251. DOI: 10.1056/NEJMoa2312282 EDN: BZUMVT
21. Molina-Infante J., Arias A., Alcedo J. et al. Empirical elimination diet for eosinophilic esophagitis in children and adults: a 2-46 study. J Allergy Clin Immunol. 2018; 141 (4): 1365-1372. DOI: 10.1016/j.jaci.2017.08.038
22. Cleaver K.L., Gonsalves N., Dellon E.S. et al. Elimination diet therapy from one product versus six products for the treatment of eosinophilic esophagitis: a multicenter randomized open trial. Lancet Gastroenterol Hepatol. 2023; 8 (5): 408-421. DOI: 10.1016/S2468-1253(23)00012-2 EDN: MMJMOR
23. Wexler J.B., Schwartz S., Arva N.K. et al. Single-food elimination diet is effective for the treatment of eosinophilic esophagitis in children. Wedge Gastroenterol Hepatol. 2022; 20 (8): 1748-1756.e11. DOI: 10.1016/j.cgh.2021.03.049
24. Coutry E., Papadopoulou A. Eosinophilic diseases of the gastrointestinal tract in childhood. J Ann is Inside. 2018; 73 (4): 18-28. DOI: 10.1159/000493668
25. Jensen E.T., Martin C.F., Kappelman M.D., Dellon E.S. Prevalence of eosinophilic gastritis, gastroenteritis, and colitis: estimates from a National Administrative Database. J Pediatr Gastroenterol Nutr. 2016; 62 (1): 36-42. DOI: 10.1097/MPG.0000000000000865
26. Yamamoto M., Nagashima S., Yamada Y. et al. Comparison of nonesophageal eosinophilic gastrointestinal disorders with eosinophilic esophagitis: a nationwide survey. J Allergy Clin Immunol Pract. 2021; 9 (9): 3339-3349. e8. DOI: 10.1016/j.jaip.2021.06.026 EDN: SMVUPQ
27. Pesek R.D., Reed C.C., Muir A.B. et al. Increasing rates of diagnosis, substantial co-occurrence, and variable treatment patterns of eosinophilic gastritis, gastroenteritis, and colitis based on 10-year data across a multicenter consortium. Am J Gastroenterol. 2019; 114 (6): 984-994. DOI: 10.14309/ajg.0000000000000228
28. Zadeh-Esmaeel M.M., Rezaei-Tavirani M., Ali Ahmadi N., Vafae R. Evaluation of gene expression change in eosinophilic gastroenteritis. J Gastroenterol Hepatol Bed Bench. 2019; 12 (3): 239-245. PMID: 31528308 PMCID: PMC6668767. PMID: 31528308
29. Shoda T., Wen T., Caldwell J.M. et al. Molecular, endoscopic, histologic, and circulating biomarker-based diagnosis of eosinophilic gastritis: multi-site study. J Allergy Clin Immunol. 2020; 145 (1): 255-269. DOI: 10.1016/j.jaci.2019.11.007 EDN: LEPUWV
30. Li K., Gechong R., Shuang L. et al. Eosinophilic gastroenteritis: pathogenesis, diagnosis, and treatment. Chin Med J (Engl.). 2023; 136 (8): 899-909. DOI: 10.1097/CM9.000000000000002511
31. Licari A., Votto M., D’Auria E. et al. Eosinophilic Gastrointestinal Diseases in Children: A Practical Review. Curr Pediatr Rev. 2020; 16 (2): 106-114. DOI: 10.2174/1573396315666191022154432 EDN: GOWJCF
32. Votto M., Lenti M.V, De Silvestri A. et al. Evaluation of diagnostic time in pediatric patients with eosinophilic gastrointestinal disorders according to their clinical features. Ital J Pediatr. 2023; 49 (1): 9. DOI: 10.1186/s13052-023-01410-1
33. Pesek R.D., Reed C.C., Collins M.H. et al. Association between endoscopic and histologic findings in a multicenter retrospective cohort of patients with non-esophageal eosinophilic gastrointestinal disorders. J Dig Dis Sci. 2020; 65: 2024-2035. DOI: 10.1007/s10620-019-05961-4
34. Kennedy K., Muir A.B., Grossman A., et al. Modified oral entericcoated budesonide regimens to treat pediatric eosinophilic gastroenteritis, a single center experience. J Allergy Clin Immunol Pract. 2019; 7 (6): 2059-2061. DOI: 10.1016/j.jaip.2019.01.053
35. Guo H., Ji X., Yang G., Jin Y. Abnormal thymic stromal lymphopoietin expression in the gastrointestinal mucosa of patients with eosinophilic gastroenteritis. J Pediatr (Rio J). 2020; 96 (3): 350-355. DOI: 10.1016/j.jped.2018.11.012
36. Корниенко Е.А., Моисеенкова Ю.А., Волкова Н.Л. и др. Эозинофильные поражения желудка и кишечника: клиника, диагностика, лечение. Альманах клинической медицины. 2018; 46 (5): 482-496. DOI: 10.18786/2072-0505-2018-46-5-482-496 EDN: YNLUAH
37. Caldwell J.M., Collins M.H., Stucke E.M., et al. Histologic eosinophilic gastritis is a systemic disorder associated with blood and extragastric eosinophilia, TH2 immunity, and a unique gastric transcriptome. J Allergy Clin Immunol. 2014 Nov; 134 (5): 1114-1124. Epub 2014 Sep 15. PMID: 25234644; PMC4254306. DOI: 10.1016/j.jaci.2014.07.026 PMID: 25234644
38. Koutria E., Paterelib A., Nonia M., et al. Distribution of eosinophilis in the gastrointestinal tract of children with no organic disease. Annals of Gastroenterology. 2020; 33: 508-515.